Cited by 253Hormonal and reproductive studiesPharmaceutical industry and healthcareAdrenal Hormones and Disorders

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Global trends in testosterone prescribing, 2000–2011: expanding the spectrum of prescription drug misuse

Handelsman, David J·2013·Medical Journal of Australia

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To provide the first multinational survey of temporal trends in testosterone prescribing, given that anecdotal evidence indicates that it is increasing in some countries, including Australia. DESIGN: Sales data for all testosterone products were obtained for 41 countries for each year from 2000 to 2011. For each testosterone product type (injectable, implantable, oral, transdermal), units sold were converted into defined monthly doses per year, reflecting total testosterone prescribing per product. MAIN OUTCOME MEASURES: National testosterone prescribing rate overall and per product type on a per capita basis. RESULTS: For every region and 37 of 41 countries, there was a major and progressive increase in defined monthly doses per year per capita over the 11 years surveyed. In most countries, the increases were steeper for the last half of the survey period. The proportion of testosterone prescribing represented by transdermal testosterone products, a surrogate measure of prescribing for older men, increased even more than did the total usage of testosterone products. CONCLUSIONS: In the absence of any new indications, off-label testosterone prescribing has increased in most countries in 2000-2011, especially over the last half of the period. The increased testosterone prescribing appears to be primarily for older men and driven by clinical guidelines that endorse testosterone prescribing for age-related functional androgen deficiency (andropause). By eliminating the fundamental distinction between pathological and functional androgen deficiency, these guidelines tacitly promote increased testosterone prescribing, bypassing the requirement for high-quality clinical evidence of safety and efficacy and creating dramatic increases in prescription of testosterone products.

Integrity signals

Registry

Crossref · 10.5694/mja13.10111

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study
Bojesen, A., Juul, S., & Gravholt, C. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021491 · Cited by 894
Prevalence of hypogonadism in males aged at least 45 years: the HIM study
MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., & MCWHIRTER, C. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00992.x · Cited by 767
Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study
Araujo, A. B., O’Donnell, A. B., Brambilla, D. J., Simpson, W. B., Longcope, C., Matsumoto, A. M., & McKinlay, J. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031719 · Cited by 591
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
Xu, L., Freeman, G., Cowling, B. J., & Schooling, C. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-108 · Cited by 569
Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
Wang, C., Nieschlag, E., Swerdloff, R. S., Behre, H. M., Hellstrom, W. J. G., Gooren, L. J., Kaufman, J., Legros, J. J., Lunenfeld, B., Morales, Á., et al. (2008) · Journal of Andrology · doi:10.2164/jandrol.108.006486 · Cited by 443
Trends in androgen prescribing in the United States, 2001 to 2011
Baillargeon, J., Urban, R. J., Ottenbacher, K. J., Pierson, K. S., & Goodwin, J. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.6895 · Cited by 336

Show all 34 references

Research works printed but not linked: 1

Braun SR, 2013, Promoting “low T”: a medical writer's perspective, JAMA Intern Med

Sorted by citations

Using human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
A Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications
Goldman, A. L., Bhasin, S., Wu, F. C. W., Krishna, M., Matsumoto, A. M., & Jasuja, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00025 · Cited by 414
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis
Corona, G., Maseroli, E., Rastrelli, G., Isidori, A. M., Sforza, A., Mannucci, E., & Maggi, M. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.950653 · Cited by 297
Testosterone Therapy and Cardiovascular Risk: Advances and Controversies
Morgentaler, A., Miner, M. M., Caliber, M., Guay, A. T., Khera, M., & Traish, A. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.011 · Cited by 213
Testosterone replacement therapy and cardiovascular risk
Gagliano‐Jucá, T., & Basaria, S. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0211-4 · Cited by 200
Testosterone Lab Testing and Initiation in the United Kingdom and the United States, 2000 to 2011
Layton, J. B., Li, D., Meier, C. R., Sharpless, J. L., Stürmer‎, T., Jick, S. S., & Brookhart, M. A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3570 · Cited by 197
Human reproduction and health: an evolutionary perspective
Jasieńska, G., Bribiescas, R. G., Furberg, A., Helle, S., & la Mora, A. N. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30573-1 · Cited by 193
Testosterone treatment and risk of venous thromboembolism: population based case-control study
Martinez, C., Suissa, S., Rietbrock, S., Katholing, A., Freedman, B., Cohen, A. T., & Handelsman, D. J. (2016) · BMJ · doi:10.1136/bmj.i5968 · Cited by 181
Self-citation
Hypogonadism and male obesity: Focus on unresolved questions
Grossmann, M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13723 · Cited by 164
The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men
Dean, J. D., McMahon, C. G., Guay, A. T., Morgentaler, A., Althof, S. E., Becher, E. F., Bivalacqua, T. J., Burnett, A. L. “., Buvat, J., Meliegy, A. E., et al. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12952 · Cited by 159
Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE)
Isidori, A. M., Aversa, A., Calogero, A. E., Ferlin, A., Francavilla, S., Lanfranco, F., Pivonello, R., Rochira, V., Corona, G., & Maggi, M. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01859-7 · Cited by 163
Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk
Michaud, J. E., Billups, K. L., & Partin, A. W. (2015) · Therapeutic Advances in Urology · doi:10.1177/1756287215597633 · Cited by 143
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health
Alemany, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911952 · Cited by 150
Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank
Luo, S., Yeung, S. L. A., Zhao, J. V., Burgess, S., & Schooling, C. M. (2019) · BMJ · doi:10.1136/bmj.l476 · Cited by 130
Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy
Yeap, B. B., Grossmann, M., McLachlan, R. I., Handelsman, D. J., Wittert, G. A., Conway, A. J., Stuckey, B. G., Lording, D. W., Allan, C. A., Zajac, J. D., et al. (2016) · Medical Journal of Australia · doi:10.5694/mja16.00393 · Cited by 135
Self-citation
Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis
Alexander, G. C., Iyer, G. S., Lucas, E. J., Lin, D. H., & Singh, S. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.09.017 · Cited by 120
Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013
Layton, J. B., Kim, Y., Alexander, G. C., & Emery, S. (2017) · JAMA · doi:10.1001/jama.2016.21041 · Cited by 116
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
Hudson, J., Cruickshank, M., Quinton, R., Aucott, L. S., Aceves‐Martins, M., Gillies, K., Bhasin, S., Snyder, P. J., Ellenberg, S. S., Grossmann, M., et al. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(22)00096-4 · Cited by 115
Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use
Coward, R. M., & McBride, J. (2016) · Asian Journal of Andrology · doi:10.4103/1008-682x.173938 · Cited by 114
Testosterone deficiency in the aging male
McBride, J. A., Carson, C. C., & Coward, R. M. (2015) · Therapeutic Advances in Urology · doi:10.1177/1756287215612961 · Cited by 109
Testosterone and Cardiovascular Health
Elagizi, A., Köhler, T., & Lavie, C. J. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.11.006 · Cited by 106
Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology
Narinx, N., David, K., Walravens, J., Vermeersch, P., Claessens, F., Fiers, T., Lapauw, B., Antonio, L., & Vanderschueren, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04562-1 · Cited by 96
Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis
Eriksson, J., Haring, R., Grarup, N., Vandenput, L., Wallaschofski, H., Lorentzen, E., Hansen, T., Mellström, D., Pedersen, O., Nauck, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176277 · Cited by 101
Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials
Trost, L. W., & Mulhall, J. P. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.068 · Cited by 98
Androgen Misuse and Abuse
Handelsman, D. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab001 · Cited by 104
Self-citation
The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
Kaur, H., & Werstuck, G. H. (2021) · CJC Open · doi:10.1016/j.cjco.2021.05.007 · Cited by 98
Hormones and Aging: An Endocrine Society Scientific Statement
Cappola, A. R., Auchus, R. J., Fuleihan, G. E., Handelsman, D. J., Kalyani, R. R., McClung, M. R., Stuenkel, C. A., Thorner, M. O., & Verbalis, J. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad225 · Cited by 108
Self-citation
Free Testosterone: Pumping up the Tires or Ending the Free Ride?
Handelsman, D. J. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00171 · Cited by 78
Self-citation
Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive-Age Men in the United States
Rao, P., Boulet, S. L., Mehta, A., Hotaling, J. M., Eisenberg, M. L., Honig, S. C., Warner, L., Kissin, D. M., Nangia, A. K., & Ross, L. S. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.10.063 · Cited by 77
The practical management of testosterone deficiency in men
Aversa, A., & Morgentaler, A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.238 · Cited by 75
The Bull of Wall Street: Experimental Analysis of Testosterone and Asset Trading
Nadler, A., Jiao, P., Johnson, C. J., Alexander, V., & Zak, P. J. (2017) · Management Science · doi:10.1287/mnsc.2017.2836 · Cited by 65
Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
Mohammadi‐Shemirani, P., Chong, M., Pigeyre, M., Morton, R. W., Gerstein, H. C., & Paré, G. (2020) · eLife · doi:10.7554/elife.58914 · Cited by 70
Effect of Testosterone Treatment on Constitutional and Sexual Symptoms in Men With Type 2 Diabetes in a Randomized, Placebo-Controlled Clinical Trial
Gianatti, E. J., Dupuis, P., Hoermann, R., Zajac, J. D., & Grossmann, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1872 · Cited by 67
Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men
Borst, S. E., & Yarrow, J. F. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00111.2015 · Cited by 63
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS
Rastrelli, G., O'Neill, T. W., Ahern, T., Bártfai, G., Casanueva, F. F., Forti, G., Keevil, B., Giwercman, A., Han, T. S., Slowikowska‐Hilczer, J., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13756 · Cited by 69
Male hypogonadism: pathogenesis, diagnosis, and management
de Silva, N. L., Papanikolaou, N., Grossmann, M., Antonio, L., Quinton, R., Anawalt, B. D., & Jayasena, C. N. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00199-2 · Cited by 68
Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30‐week randomized placebo‐controlled study
Hackett, G. I., Cole, N., Saghir, A. N., Jones, P. W., Strange, R. C., & Ramachandran, S. (2016) · British Journal of Urology · doi:10.1111/bju.13516 · Cited by 58
Testosterone boosts physical activity in male mice via dopaminergic pathways
Jardí, F., Laurent, M. R., Kim, N., Khalil, R., Bundel, D. D., Eeckhaut, A. V., Helleputte, L. V., Deboel, L., Dubois, V., Schollaert, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-19104-0 · Cited by 56
Age-related testosterone decline: mechanisms and intervention strategies
Cheng, H., Zhang, X., Li, Y., Cao, D., Luo, C., Zhang, Q., Zhang, S., & Jiao, Y. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01316-5 · Cited by 67
Androgen Physiology, Pharmacology, and Abuse
Handelsman, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00138-4 · Cited by 54
Self-citation
Testosterone, aging and survival
Shores, M. M., & Matsumoto, A. M. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000057 · Cited by 52
Testosterone Replacement Therapy and Cardiovascular Risk: A Review
Giovanni Corona, G., Rastrelli, G., Maseroli, E., Sforza, A., & Maggi, M. (2015) · The World Journal of Men s Health · doi:10.5534/wjmh.2015.33.3.130 · Cited by 51
Marketing and Testosterone Treatment in the USA: A Systematic Review
Bandari, J., Ayyash, O. M., Emery, S., Wessel, C. B., & Davies, B. J. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.10.016 · Cited by 51
Disease Mongering of Age‐Associated Declines in Testosterone and Growth Hormone Levels
Perls, T. T., & Handelsman, D. J. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13391 · Cited by 47
Self-citation
Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials
Ayele, H. T., Brunetti, V. C., Renoux, C., Tagalakis, V., & Filion, K. B. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2020.12.029 · Cited by 48
Testosterone and cardiovascular disease risk
Yeap, B. B. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000161 · Cited by 44
Complications of injectable testosterone undecanoate in routine clinical practice
Middleton, T. L., Turner, L., Fennell, C., Savkovic, S., Jayadev, V., Conway, A. J., & Handelsman, D. J. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0891 · Cited by 44
Self-citation
Testosterone treatment in older men: clinical implications and unresolved questions from the Testosterone Trials
Yeap, B. B., Page, S. T., & Grossmann, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30416-3 · Cited by 43
Testosterone and Male Aging
Handelsman, D. J. (2017) · JAMA · doi:10.1001/jama.2017.0129 · Cited by 42
Self-citation
Andropause – lessons from the European Male Ageing Study
Huhtaniemi, I. T. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.03.005 · Cited by 44
Current and future trends in men’s health clinics
Houman, J., Eleswarapu, S. V., & Mills, J. N. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2019.08.33 · Cited by 41
Testosterone Replacement Therapy in Hypogonadal Men
Wang, C., & Swerdloff, R. S. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.005 · Cited by 48
Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis
Hudson, J., Cruickshank, M., Quinton, R., Aucott, L. S., Wu, F. C. W., Grossmann, M., Bhasin, S., Snyder, P. J., Ellenberg, S. S., Travison, T. G., et al. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00169-1 · Cited by 41
Patterns of testosterone prescription overuse
Jasuja, G. K., Bhasin, S., & Rose, A. J. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000336 · Cited by 39
Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels
Walsh, T. J., Shores, M. M., Krakauer, C. A., Forsberg, C. W., Fox, A., Moore, K. P., Korpak, A. M., Heckbert, S. R., Zeliadt, S. B., Kinsey, C. E., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199194 · Cited by 39
Trends and Patterns of Testosterone Therapy among U.S. Male Medicare Beneficiaries, 1999 to 2014
Zhou, C. K., Advani, S., Chaloux, M., Gibson, J. T., Yu, M., Bradley, M. C., Hoover, R. N., & Cook, M. B. (2020) · The Journal of Urology · doi:10.1097/ju.0000000000000744 · Cited by 38
Testosterone and exercise: effects on fitness, body composition, and strength in middle-to-older aged men with low-normal serum testosterone levels
Chasland, L. C., Yeap, B. B., Maiorana, A., Chan, Y. X., Maslen, B. A., Cooke, B. R., Dembo, L. G., Naylor, L. H., & GREEN, D. J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00010.2021 · Cited by 39
Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations
Morgentaler, A., & Conners, W. P. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.148067 · Cited by 35
The Impact of Drug Reimbursement Policy on Rates of Testosterone Replacement Therapy among Older Men
Piszczek, J., Mamdani, M., Antoniou, T., Juurlink, D. N., & Gomes, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098003 · Cited by 34
Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem
Irwig, M. S., Fleseriu, M., Jonklaas, J., Tritos, N. A., Yuen, K. C. J., Correa, R. R., Elhomsy, G. C., Garla, V. V., Jasim, S., Soe, K. K., et al. (2020) · Endocrine Practice · doi:10.4158/ps-2019-0540 · Cited by 35
Endogenous Testosterone Levels and the Risk of Incident Cardiovascular Events in Elderly Men: The MrOS Prospective Study
Collet, T., Ewing, S. K., Ensrud, K. E., Laughlin, G. A., Hoffman, A. R., Varosy, P. D., Stefanick, M. L., Stone, K. L., ORWOLL, E. S., & Bauer, D. C. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa038 · Cited by 31
Testosterone Supplementation and Cognitive Functioning in Men—A Systematic Review and Meta-Analysis
Buskbjerg, C. R., Gravholt, C. H., Dalby, H. R., Amidi, A., & Zachariae, R. H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00119 · Cited by 37
Centennial perspective on human adaptability
Leonard, W. R. (2018) · American Journal of Physical Anthropology · doi:10.1002/ajpa.23401 · Cited by 34
Regulation of local steroidogenesis in the brain and in prostate cancer: Lessons learned from interdisciplinary collaboration
Fokidis, H. B., Adomat, H. H., Kharmate, G., Beheshti, E. H., Guns, E. S. T., & Soma, K. K. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.08.005 · Cited by 31
Trends in Testosterone Prescription and Public Health Concerns
Gabrielsen, J. S., Najari, B. B., Alukal, J. P., & Eisenberg, M. L. (2016) · Urologic Clinics of North America · doi:10.1016/j.ucl.2016.01.010 · Cited by 31
Enclomiphene citrate for the treatment of secondary male hypogonadism
Rodríguez, K. M. G., Pastuszak, A. W., & Lipshultz, L. I. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1204294 · Cited by 32
Role of Testosterone in the Treatment of Cardiovascular Disease
Webb, C. M., & Collins, P. D. (2017) · European Cardiology Review · doi:10.15420/ecr.2017:21:1 · Cited by 31
Long-Term Treatment Patterns of Testosterone Replacement Medications
Donatucci, C. F., Cui, Z. L., Fang, Y. H., & Muram, D. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12608 · Cited by 29
Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans
Walsh, T. J., Shores, M. M., Fox, A., Moore, K. P., Forsberg, C. W., Kinsey, C. E., Heckbert, S. R., Zeliadt, S. B., Thompson, M. L., Smith, N. L., et al. (2015) · Andrology · doi:10.1111/andr.12014 · Cited by 26
Childhood ecology influences salivary testosterone, pubertal age and stature of Bangladeshi UK migrant men
Magid, K. S., Chatterton, R. T., Ahamed, F. U., & Bentley, G. R. (2018) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0567-6 · Cited by 25
Accuracy of Testosterone Concentrations in Compounded Testosterone Products
Grober, E. D., Garbens, A., Božović, A., Kulasingam, V., Fanipour, M., & Diamandis, E. P. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12898 · Cited by 27
Approach to the Patient: Low Testosterone Concentrations in Men With Obesity
Muir, C. A., Wittert, G., & Handelsman, D. J. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf137 · Cited by 26
Self-citation
Controversies in Testosterone Therapy
Twitchell, D. K., Pastuszak, A. W., & Khera, M. (2020) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2020.09.004 · Cited by 27
Comparing the Impacts of Testosterone and Exercise on Lean Body Mass, Strength and Aerobic Fitness in Aging Men
GREEN, D. J., Chasland, L. C., Yeap, B. B., & Naylor, L. H. (2024) · Sports Medicine - Open · doi:10.1186/s40798-024-00703-x · Cited by 28
Testosterone therapy and prostate cancer—safety concerns are well founded
Klotz, L. H. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2014.338 · Cited by 24
Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer’s disease
Hall, J. R., Wiechmann, A. R., Cunningham, R. L., Johnson, L. A., Edwards, M., Barber, R. C., Singh, M., Winter, S., & O’Bryant, S. E. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0107-4 · Cited by 23
Clinical practice patterns in the assessment and management of low testosterone in men: an international survey of endocrinologists
Grossmann, M., Anawalt, B. D., & Wu, F. C. W. (2014) · Clinical Endocrinology · doi:10.1111/cen.12594 · Cited by 23
State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males
Elsherbiny, A., Tricomi, M., Bhatt, D., & Dandapantula, H. K. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0838-x · Cited by 23
A new 2% testosterone gel formulation: a comparison with currently available topical preparations
Arver, S., Stief, C. G., de la Rosette, J. J. M. C. H., Jones, T. H., Neijber, A., & Carrara, D. (2018) · Andrology · doi:10.1111/andr.12487 · Cited by 23
Dose-Response Relationships Between Gonadal Steroids and Bone, Body Composition, and Sexual Function in Aging Men
Finkelstein, J. S., Lee, H., Burnett‐Bowie, S. M., Darakananda, K., Gentile, E. C., Goldstein, D. W., Prizand, S. H., Krivicich, L. M., Taylor, A. P., Wulczyn, K. E., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa318 · Cited by 23
Irrational Exuberance in Testosterone Prescribing: When Will the Bubble Burst?
Handelsman, D. J. (2015) · Medical Care · doi:10.1097/mlr.0000000000000416 · Cited by 22
Self-citation
Testosterone, frailty and physical function in older men
Hsu, B., Cumming, R. G., & Handelsman, D. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1475227 · Cited by 22
Self-citation
Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men
Dias, J. P., Melvin, D. L., Shardell, M. D., Ferrucci, L., Chia, C. W., Gharib, M., Egan, J. M., & Basaria, S. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1111 · Cited by 22
Effects of testosterone and progressive resistance exercise on vascular function in older men
Hildreth, K. L., Schwartz, R. S., Griend, J. P. V., Kohrt, W. M., Blatchford, P. J., & Moreau, K. L. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00165.2018 · Cited by 21
Testosterone and the risk of incident atrial fibrillation in older men: further analysis of the ASPREE study
Tran, C., Yeap, B. B., Ball, J., Clayton‐Chubb, D., Hussain, S. M., Brodtmann, A. G., Tonkin, A. M., Neumann, F., Schneider, H. G., Fitzgerald, S. M., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102611 · Cited by 22
Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment: comment
Xu, L., & Schooling, C. M. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12862 · Cited by 20
Obstructive Sleep Apnea is Associated with Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy
Lundy, S. D., Parekh, N. V., & Shoskes, D. A. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.03.006 · Cited by 21
History of androgens and androgen action
Handelsman, D. J. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101629 · Cited by 19
Self-citation
Genetically predicted testosterone and electrocardiographic QT interval duration in Chinese: a Mendelian randomization analysis in the Guangzhou Biobank Cohort Study
Zhao, J. V., Jiang, C., Lam, T., Liu, B., Cheng, K. K., Xu, L., Long, M. J., Zhang, W., Leung, G. M., & Schooling, C. M. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu241 · Cited by 18
The marketing of testosterone treatments for age-related low testosterone or ‘Low T’
Mintzes, B. J. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000412 · Cited by 18
Hormone replacement therapy and longevity
Comhaire, F. H. (2015) · Andrologia · doi:10.1111/and.12419 · Cited by 18
Sex, Energy, Well-Being and Low Testosterone: An Exploratory Survey of U.S. Men’s Experiences on Prescription Testosterone
Straftis, A. A., & Gray, P. B. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16183261 · Cited by 18
Testosterone and Exercise in Middle-to-Older Aged Men
Chasland, L. C., Naylor, L. H., Yeap, B. B., Maiorana, A., & GREEN, D. J. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16411 · Cited by 17
Testosterone replacement therapy: clinical considerations
Luther, P. M., Spillers, N. J., Talbot, N. C., Sinnathamby, E. S., Ellison, D., Kelkar, R. A., Ahmadzadeh, S., Shekoohi, S., & Kaye, A. D. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2306832 · Cited by 17
Testosterone and the Prostate
DeLay, K. J., & Köhler, T. (2016) · Urologic Clinics of North America · doi:10.1016/j.ucl.2016.04.011 · Cited by 17
Establishing normal values of total testosterone in adult healthy men by the use of four immunometric methods and liquid chromatography-mass spectrometry
Montagna, G., Balestra, S., D’Aurizio, F., Romanelli, F., Benagli, C., Tozzoli, R., Risch, L., Giovanella, L., & Imperiali, M. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1201 · Cited by 17
Effects of testosterone treatment, with and without exercise training, on ambulatory blood pressure in middle‐aged and older men
Chasland, L. C., GREEN, D. J., Schlaich, M. P., Maiorana, A., Cooke, B. R., Cox, K. L., Naylor, L. H., & Yeap, B. B. (2021) · Clinical Endocrinology · doi:10.1111/cen.14442 · Cited by 19
The association of cardiorespiratory fitness, body mass index, and age with testosterone levels at screening of healthy men undergoing preventive medical examinations: The Cooper Center Longitudinal Study
DeFina, L. F., Radford, N. B., Leonard, D. S., Wilson, R. K., Cooper, T. C., Clark, S. M., Willis, B. L., Vega, G. L., Barlow, C. E., Farrell, S. W., et al. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.09.004 · Cited by 16
Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems
Bhatia, R., Murphy, A. B., Raper, J. L., Chamie, G., Kitahata, M. M., Drozd, D. R., Mayer, K. H., Napravnik, S., Moore, R. D., & Achenbach, C. J. (2014) · AIDS · doi:10.1097/qad.0000000000000521 · Cited by 16
Trenbolone Improves Cardiometabolic Risk Factors and Myocardial Tolerance to Ischemia-Reperfusion in Male Rats With Testosterone-Deficient Metabolic Syndrome
Donner, D. G., Elliott, G. E., Beck, B. R., Bulmer, A. C., Lam, A. K.-Y., Headrick, J. P., & Toit, E. F. D. (2015) · Endocrinology · doi:10.1210/en.2015-1603 · Cited by 16

Authors: Handelsman, D. J.
Affiliations: The University of Sydney (AU)
Corresponding author: Handelsman, David J
ORCID: Handelsman, David J
Venue: Medical Journal of Australia
Publisher: AMPCo
Published: 2013-10
Volume: 199
Issue: 8
Pages: 548-551
ISSN: 0025-729X (ISSN-L)
1326-5377
DOI: 10.5694/mja13.10111
OpenAlex: W2068541344
Cited by: 253
References: 34
Citations by year: 2026: 12 · 2025: 18 · 2024: 15 · 2023: 14 · 2022: 19 · 2021: 14 · 2020: 18 · 2019: 12 · 2018: 26 · 2017: 32 · 2016: 21 · 2015: 30 · 2014: 22
FWCI: 19.14
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 20 d)
doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
Locations: The Medical Journal of Australia (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords: prescription drug misuse, off-label drug use, andropause, transdermal testosterone, testosterone implants, clinical guidelines, older men
MeSH terms: Australia, Cross-Cultural Comparison, Forecasting, Health Surveys, Humans, Male, Practice Patterns, Physicians', Testosterone, Health Care Costs, Evidence-Based Medicine, Hormone Replacement Therapy, Andropause, Off-Label Use, Prescription Drug Misuse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Global trends in testosterone prescribing, 2000–2011: expanding the spectrum of prescription drug misuse

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks